Application of Metagenomics approaches for Crohn’s Disease Istanbul University

Main Article Content

Omar Sajer Naser
Elmira Davasaz Tabrizi
Dr. Ercan Arican

Keywords

Crohn’s disease. Gastrointestinal. Metagenomics

Abstract

Crohn’s Disease (CD) also called the Chronic inflammation of the intestinal system, as well known as regional enteritis or regional ileitis generally occurs in the terminal segment of the ileum, the section of the small bowel farthest from the stomach (Barbara A. Schreiber, 2022). The study's aim was to identify the differences in the gut microbiome composition between patients with and without CD, as
well as compare them with healthy control samples (a total of 35 human blood samples). This study is focusing on the mutations/variations in innate immunity and adaptive immunity genes, which increase the risk of inflammatory bowel disease. With that, it aimed to evaluate the effects of mutations on microbiota balance and dysbiosis observed in CD patients (Petagna L et al., 2020). As indicated in the results, we found the first principal coordinate which shows a percentage of 55.09% for the PC1 while showing a percentage of 22.26% for the C2. Moreover, the other principal coordinate shows a percentage of 55.09% for the PC1 while showing a percentage of 9.39% for the C2. Additionally, In  the taxonomic classification, we found that bacterial community was found in samples C1 and C2 as similar to a CD. According to the results, all the microorganisms present are bacteria, but with differences in the phylum, order, family, genus, and species. Furthermore, it can be inferred that at the phylum level, the dominant bacteria are proteobacteria, at the class level, the dominant ones are gammaproteobacteria while at the order level, the dominant ones are pseudomonadellas.

Abstract 220 | pdf Downloads 157

References

1. Ahmed M., 2021. Crohn's Disease recent advances. IntechOpen. p. 106. DOI: 10.5772/intechopen.97103, Book.
2. Barbara A., Schreiber. 2022. Crohns Disease. The Editors of Encyclopaedia Britannica. https://www.britannica.com/science/Crohndisease.
3. Fiorindi C. et al., 2020. Nutritional adequacy in surgical IBD patients, clinical nutrition ESPEN. Volume 14.
4. Konopiński M.K., 2020. Shannon diversity index: a call to replace the original Shannon’s formula with unbiased estimator in the population
genetics studies. Bioinformatics and Genomics,PeerJ 8:e9391 https://doi.org/10.7717/peerj.9391
5. Ma, et al., 2021. Metagenome Analysis of Intestinal Bacteria in Healthy People. Patients with Inflammatory Bowel Disease and Colorectal
Cancer. Journal Frontieres in Cellular and Infectious Microbiology. Volume 11.
6. Petagna L. et al., 2020. Pathophysiology of Crohn’s disease inflammation and recurrence. Biology Direct. Volume 15. Article number 23.
7. Roda G. et al., 2020. Crohn’s disease. Nature Reviews Disease Primers. Volume 6. Article number 22.
8. Segal A W, 2019, Studies on patients establish Crohn’s disease as a manifestation of impaired innate immunity, Journal of Internal Medicine,
Volume 286, Issue 4.
9. Vrakas S. et al., 2017. Intestinal Bacteria Composition and Translocation of Bacteria in Inflammatory Bowel Disease. Journal pone.
Volume 12. Issue 1.
10. Kondo K. et al., 2019. The association between environmental factors and the development of Crohn’s disease with focusing on passive
smoking: a multicenter case- control study in Japan. PLoS One. Volume 14.
11. Khalili H. et al., 2020. Adherence to a Mediterranean diet is associated with a lower risk of later- onset Crohn’s disease: results from two
large prospective cohort studies. BMJ Journals. Gut. Volume 69. Issue 9.
12. Ahlostrom G., 2022. Metagenomic analysis of crohn’s disease. UPTEC X 22031. Uppsala University.
13. Gammoh N., 2020. The multifaceted functions of ATG16L1 in autophagy and related processes. Journal of Cell Science. Volume 133. Issue 20